|Previous Section||Index||Home Page|
5 Jan 2004 : Column 184Wcontinued
Mr. Burstow: To ask the Secretary of State for Health pursuant to his answer of 10 December, Official Report, columns 5023W, on departmental staff, (1) if he will list the job titles of each member of staff in the Health and Social Care Delivery Group; 
(3) if he will list the job titles of each member of staff in the Strategy and Business Development Group. 
Ms Rosie Winterton: The Department is currently undergoing an extensive change programme. The basic framework has been agreed and was detailed in my previous answer. Job titles and details of the structure are subject to confirmation by group directors.
Mr. Burstow: To ask the Secretary of State for Health pursuant to his answer of 10 December, Official Report, columns 5023W, on departmental staff, what the activities are of each business group. 
5 Jan 2004 : Column 185W
Health Protection, International Health and Scientific Development
Research and Development
Quality and Standards
Regional Public Health
Group Business Team
Corporate Human Resources
Medicines Pharmacy and Industry
Improving Patient Experience Programme
Media Centre Campaign
Programmes and Planning
Corporate Analytical Centre
System and Policy Development
5 Jan 2004 : Column 186W
Finance and Investment
Information Systems and National Programme Delivery
Programmes and Performance
Group Business Team
Ms Rosie Winterton: We recognised that the Department must change to reflect recent changes in the national health service and social care. It was clear that, with the Government's focus on shifting power to the frontline and the formation of many independent bodies, the Department's role and functions would reduce. We decided a reduction of at least a third was necessary to reflect our new role in providing strategic direction and leadership to the NHS and social care.
The radical Change Programme will reduce the size of the core Department by 1,400from over 3,600 posts to 2,200by October 2004. This represents a 38 per cent. reduction at the centre. Half of those posts will not be replaced and will be achieved by efficiency savings, while the rest of the reduction will result from transferring posts to other national bodies, which are also the subject of review.
We have indicated our intention to maintain the current proportion of Departmental staff in Leeds and London. The final numbers at each location are yet to be finalised. We estimate that most of the reductions will be through natural turnover or early retirements. A voluntary scheme has already been launched for those over 50. The Department has had a 'vacancy freeze' in place for the last six months, to ensure staff are given the best opportunities to seek alternative posts, and we are actively monitoring turnover. The Department is using professional support to help those staff affected by the changes.
Mr. Hutton: An evaluation of National Health Service treatment centres has been commissioned from a consortium made up of University College London and the University of Southampton, under the NHS service delivery and organisation research programme. The evaluation began in March 2003 and is being carried out over three years.
Gregory Barker: To ask the Secretary of State for Health what his estimate is of the earnings of (a) a locum doctor and (b) a doctor with a permanent position within an NHS trust in the last year for which figures are available. 
5 Jan 2004 : Column 187W
|Staff grade||Mean year earnings (£)|
|Non-consultant career grades||56,751|
|Other hospital grades||58,103|
|Senior house officer||41,124|
Dr. Ladyman: As at 30 November, 4,322 domiciliary care providers have applied for registration. 3,155 of these applications have been validated and are being processed, and 243 domiciliary care providers met the registration standard.
|Yorkshire and Humberside||6|
Information as at 30 November 2003.
Dr. Gibson: To ask the Secretary of State for Health (1) how he plans to incorporate guidance from the National Institute for Clinical Excellence on drug eluting stents into the National Standards Framework on coronary heart disease; 
Miss Melanie Johnson: The national service framework for coronary heart disease (NSF CHD), published in March 2000, sets the agenda for the modernisation of CHD services over a 10 year period. Standard 10 deals with revascularisation and states that
5 Jan 2004 : Column 188W
The NICE guidance estimates that the additional cost of drug eluting stents would be between £6 million and £7.2 million per year, assuming the use of about 12,000 DES costing an additional £500 to £600 each.
|Next Section||Index||Home Page|